Among individuals with a clinically significant decrease in visceral adipose tissue, tesamorelin was effective in increasing the density of truncal muscle groups and the total area of the rectus and psoas muscles 6
While some clinical investigations indicate that combination therapy primarily exhibits gastrointestinal-related adverse effects without significant escalation in overall adverse event incidence 14,15 , contrasting expert opinions advocate for metformin dose reduction or discontinuation during GLP-1 receptor agonist treatment 16
219 Low vitamin D levels are associated with multiple health issues, including cardiovascular disease, which is a leading cause of death in patients with CKD
Does semaglutide GLP-1get rid of belly fat
10.1016/j.ejphar.2016.07.026 160 SasakiH.HamataniT.KamijoS.IwaiM.KobanawaM.OgawaS.et al (2019)
To reduce common side effects People using GLP-1 medications often report symptoms such as: Nausea Bloating Constipation Fatigue Reduced appetite These symptoms are often made worse by poor meal structure, skipping meals completely, eating greasy foods, or not drinking enough fluids